These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 33732282)

  • 1. ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma.
    Liu S; Geng R; Lin E; Zhao P; Chen Y
    Front Genet; 2021; 12():602160. PubMed ID: 33732282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression and prognostic value of the epidermal growth factor receptor family in glioma.
    Xu B; Huo Z; Huang H; Ji W; Bian Z; Jiao J; Sun J; Shao J
    BMC Cancer; 2021 Apr; 21(1):451. PubMed ID: 33892666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ErbBs inhibition by lapatinib blocks tumor growth in an orthotopic model of human testicular germ cell tumor.
    Juliachs M; Castillo-Ávila W; Vidal A; Piulats JM; Garcia Del Muro X; Condom E; Hernández-Losa J; Teixidó C; Pandiella A; Graupera M; Casanovas O; Germà JR; Villanueva A; Viñals F
    Int J Cancer; 2013 Jul; 133(1):235-46. PubMed ID: 23292912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
    Feroz K; Williams E; Riese DJ
    Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of ErbB1-4 expression in invasive breast cancer with clinicopathological characteristics and prognosis.
    Fujiwara S; Ibusuki M; Yamamoto S; Yamamoto Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):472-81. PubMed ID: 23100016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas.
    Silva SD; Cunha IW; Younes RN; Soares FA; Kowalski LP; Graner E
    Oral Dis; 2010 Nov; 16(8):774-80. PubMed ID: 20604875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of ERBB family mRNA expression in breast carcinomas.
    Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
    Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of ErbB1, ErbB2, and their Dual Targeting Using Small Molecules and Natural Peptides: Blocking EGFR Cell Signaling Pathways in Cancer: A Mini-Review.
    Patnaik SK; Chandrasekar MJN; Nagarjuna P; Ramamurthi D; Swaroop AK
    Mini Rev Med Chem; 2022 Oct; 22(22):2831-2846. PubMed ID: 35549881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.
    Bouyain S; Longo PA; Li S; Ferguson KM; Leahy DJ
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15024-9. PubMed ID: 16203964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.
    Mitsui K; Yonezawa M; Tatsuguchi A; Shinji S; Gudis K; Tanaka S; Fujimori S; Sakamoto C
    BMC Cancer; 2014 Nov; 14():863. PubMed ID: 25416285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERBB3 as an independent prognostic marker for nasopharyngeal carcinoma.
    Tulalamba W; Larbcharoensub N; Janvilisri T
    J Clin Pathol; 2014 Aug; 67(8):667-72. PubMed ID: 24825912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer.
    Moghbeli M; Makhdoumi Y; Soltani Delgosha M; Aarabi A; Dadkhah E; Memar B; Abdollahi A; Abbaszadegan MR
    Biol Res; 2019 Jan; 52(1):2. PubMed ID: 30621788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different patterns of expression of the erbB family of receptor tyrosine kinases in common nevi, dysplastic nevi, and primary malignant melanomas: an immunohistochemical study.
    Feinmesser M; Veltman V; Morgenstern S; Tobar A; Gutman H; Kaganovsky E; Tzabari C; Sulkes J; Okon E
    Am J Dermatopathol; 2010 Oct; 32(7):665-75. PubMed ID: 20559114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
    Roskoski R
    Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six Cell Cycle-related Genes Serve as Potential Prognostic Biomarkers and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
    Shi Y; Sang X; Deng J; Wang Y; Chen X; Lin S; Wu F; Xu A
    J Cancer; 2023; 14(1):9-23. PubMed ID: 36605491
    [No Abstract]   [Full Text] [Related]  

  • 17. ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer.
    Stern DF
    J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):215-23. PubMed ID: 18454306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121).
    Schoeberl B; Kudla A; Masson K; Kalra A; Curley M; Finn G; Pace E; Harms B; Kim J; Kearns J; Fulgham A; Burenkova O; Grantcharova V; Yarar D; Paragas V; Fitzgerald J; Wainszelbaum M; West K; Mathews S; Nering R; Adiwijaya B; Garcia G; Kubasek B; Moyo V; Czibere A; Nielsen UB; MacBeath G
    NPJ Syst Biol Appl; 2017; 3():16034. PubMed ID: 28725482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides for Dual Targeting of ErbB1 and ErbB2: Blocking EGFR Cell Signaling Transduction Pathways for Cancer Chemotherapy.
    Patnaik SK; Swaroop AK; Nagarjuna P; Nanjan MJ; Chandrasekar MJN
    Curr Mol Pharmacol; 2024; 17(1):e240223214012. PubMed ID: 36843255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERBB Signaling Pathway in Cancer Stem Cells.
    Hassan G; Seno M
    Adv Exp Med Biol; 2022; 1393():65-81. PubMed ID: 36587302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.